IO Frontiers World 2019

From science to strategy

An intimate and exclusive partnering event placing the next frontier of I-O in a strategic context whilst giving you direct access to the decision makers and KOL’s working towards the next oncology blockbuster


Scientific breakthroughs

The first place in 2018 to hear the latest scientific breakthroughs in a commercial context. Why is this important? Because events such as ASH or ASCO will put these in a scientific context however executive level players will come to Phacilitate to understand the impact it will have at board level.

I-O Collaboration lunch

I-O collaboration lunch: Meet more Big Pharma decision makers in 45 minutes than you would all year whilst enjoying the sunshine on the river walk terrace.  We are giving you access to the influencers from big pharma making this THE optimal networking opportunity for biotechs/academic centres on the hunt for clinical partnerships.

Co-location with Cell & Gene Therapy World

The only I-O event co-located with the leading Cell and Gene Therapy global meeting. Providing access to the most commercially advanced technical expertise specifically for cellular immunotherapies. 1,200+ attendees, 200+ speakers, 100+ exhibitors – it is the one meeting on the global calendar attended by all of the critical decision-makers from both inside and outside of the cell & gene therapy/immuno-oncology industry.

Brand new I-O Hub

Get closer to technology enablers and gain insight into innovative tools advancing I-O in our brand new I-O Hub. Scheduled tours and demonstrations in the hub give you access to the technologies helping you to overcome key challenges faced in both pre-clinical and clinical development.

Diverse audience of decision makers

No other event attracts such a diverse audience of decision makers representing the key voices defining commercial success. Meet more leaders representing not just the immuno-oncology biotech sector, but the world’s leading KOLs, regulators, payers, investors and big pharma. New and expanded initiatives such as the Super Plenary and CEO Forum ensure attendees of a breadth and level of influence never before seen at an event for this sector.

Fun, effective networking

Setting a brand new standard for fun, effective networking. From themed cocktail receptions on the banks of the Miami Canals through our  I-O collaboration lunch to the already-legendary Phacilitate Miami Yacht Party, Phacilitate Leaders Forum 2018 will support your partnering activities like never before.

Calling all tool and service providers!


  • Educate emerging biotechs yet to select their preferred suppliers. Through initiatives including a new Emerging Science Track and the Translation Academy, Phacilitate will engage more early stage, emerging biotech companies than any other partnering event for the sector.
  • Through the co-location with CGT we guarantee that you will be able to establish partnerships with the decision makers and implementers developing cellular therapies - a unique pool of buyers unlikely to be found at any other I-O event that need CROs/biomarkers/diagnostic tools for their clinical/pre-clinical programs


  • The first ever interactive I-O hub. Running live demos, guided tours and guaranteed decision makers to your booth. Sign up to join the hub and you will be right at the epicentre of the event- plus gain insight into market challenges via our pre-event survey


  • Phacilitate is the only event to truly support industry/academic convergence. Meet both industry and scientific KOLs under 1 roof. This means that companies can save thousands on their marketing and business development budgets!

Co-located with Cell & Gene Therapy World




  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy